Nodinitib-1 50 mg | 99.98%
TargetMol
Nodinitib-1 (CID-1088438) is a potent and selective NOD1 inhibitor with an IC50 of 0.56 μM.
More Information Supplier PageNodinitib-1
Search Results
Nodinitib-1 5 mg | 99.98%
TargetMol
Nodinitib-1 (CID-1088438) is a potent and selective NOD1 inhibitor with an IC50 of 0.56 μM.
More Information Supplier PageNodinitib-1
Refametinib 10 mg | 99.53%
TargetMol
Refametinib (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).
More Information Supplier PageRefametinib 5 mg | 99.53%
TargetMol
Refametinib (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).
More Information Supplier PageScopine 100 mg | Purity Not Available
TargetMol
Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.
More Information Supplier PageScopine
Scopine 10 mg | Purity Not Available
TargetMol
Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.
More Information Supplier PageScopine
Vilazodone Hydrochloride 10 mg | 99.92%
TargetMol
Vilazodone HCl, a partial agonist of 5-HT1A receptors and specific serotonin reuptake inhibitor (SSRI), is utilized in treating of the major depressive disorder.
More Information Supplier PageVilazodone Hydrochloride
Ribociclib 5 mg | 98.27%
TargetMol
LEE011 is an orally available, and highly specific CDK4/6 inhibitor (IC50：10/39 nM).
More Information Supplier PageRibociclib
Ribociclib 50 mg | 98.27%
TargetMol
LEE011 is an orally available, and highly specific CDK4/6 inhibitor (IC50：10/39 nM).
More Information Supplier PageRibociclib
Ribociclib 25 mg | 98.27%
TargetMol
LEE011 is an orally available, and highly specific CDK4/6 inhibitor (IC50：10/39 nM).
More Information Supplier PageRibociclib